Literature DB >> 23394784

Congenital myopathies--clinical features and frequency of individual subtypes diagnosed over a 5-year period in the United Kingdom.

L Maggi1, M Scoto, S Cirak, S A Robb, A Klein, S Lillis, T Cullup, L Feng, A Y Manzur, C A Sewry, S Abbs, H Jungbluth, F Muntoni.   

Abstract

The congenital myopathies are a group of inherited neuromuscular disorders mainly defined on the basis of characteristic histopathological features. We analysed 66 patients assessed at a single centre over a 5 year period. Of the 54 patients where muscle biopsy was available, 29 (54%) had a core myopathy (central core disease, multi-minicore disease), 9 (17%) had nemaline myopathy, 7 (13%) had myotubular/centronuclear myopathy, 2 (4%) had congenital fibre type disproportion, 6 (11%) had isolated type 1 predominance and 1 (2%) had a mixed core-rod myopathy. Of the 44 patients with a genetic diagnosis, RYR1 was mutated in 26 (59%), ACTA1 in 7 (16%), SEPN1 in 7 (16%), MTM1 in 2 (5%), NEB in 1 (2%) and TPM3 in 1 (2%). Clinically, 77% of patients older than 18 months could walk independently. 35% of all patients required ventilatory support and/or enteral feeding. Clinical course was stable or improved in 57/66 (86%) patients, whilst 4 (6%) got worse and 5 (8%) died. These findings indicate that core myopathies are the most common form of congenital myopathies and that more than half can be attributed to RYR1 mutations. The underlying genetic defect remains to be identified in 1/3 of congenital myopathies cases.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23394784     DOI: 10.1016/j.nmd.2013.01.004

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  40 in total

1.  Target resequencing of neuromuscular disease-related genes using next-generation sequencing for patients with undiagnosed early-onset neuromuscular disorders.

Authors:  Yuri Kitamura; Eri Kondo; Mari Urano; Ryoko Aoki; Kayoko Saito
Journal:  J Hum Genet       Date:  2016-06-30       Impact factor: 3.172

2.  Bayesian modeling to predict malignant hyperthermia susceptibility and pathogenicity of RYR1, CACNA1S and STAC3 variants.

Authors:  Senthilkumar Sadhasivam; Barbara W Brandom; Richard A Henker; John J McAuliffe
Journal:  Pharmacogenomics       Date:  2019-09       Impact factor: 2.533

3.  RYR1 and CACNA1S genetic variants identified with statin-associated muscle symptoms.

Authors:  Paul J Isackson; Jianxin Wang; Mohammad Zia; Paul Spurgeon; Adrian Levesque; Jonathan Bard; Smitha James; Norma Nowak; Tae Keun Lee; Georgirene D Vladutiu
Journal:  Pharmacogenomics       Date:  2018-10-16       Impact factor: 2.533

4.  Mouse model of severe recessive RYR1-related myopathy.

Authors:  Stephanie Brennan; Maricela Garcia-Castañeda; Antonio Michelucci; Nesrin Sabha; Sundeep Malik; Linda Groom; Lan Wei LaPierre; James J Dowling; Robert T Dirksen
Journal:  Hum Mol Genet       Date:  2019-09-15       Impact factor: 6.150

5.  JSA guideline for the management of malignant hyperthermia crisis 2016.

Authors: 
Journal:  J Anesth       Date:  2017-02-28       Impact factor: 2.078

Review 6.  Pathophysiological concepts in the congenital myopathies: blurring the boundaries, sharpening the focus.

Authors:  Gianina Ravenscroft; Nigel G Laing; Carsten G Bönnemann
Journal:  Brain       Date:  2014-12-31       Impact factor: 13.501

7.  Congenital myopathies: Natural history of a large pediatric cohort.

Authors:  Irene Colombo; Mariacristina Scoto; Adnan Y Manzur; Stephanie A Robb; Lorenzo Maggi; Vasantha Gowda; Thomas Cullup; Michael Yau; Rahul Phadke; Caroline Sewry; Heinz Jungbluth; Francesco Muntoni
Journal:  Neurology       Date:  2014-11-26       Impact factor: 9.910

8.  A recessive mutation in beta-IV-spectrin (SPTBN4) associates with congenital myopathy, neuropathy, and central deafness.

Authors:  Ellen Knierim; Esther Gill; Franziska Seifert; Susanne Morales-Gonzalez; Sathya D Unudurthi; Thomas J Hund; Werner Stenzel; Markus Schuelke
Journal:  Hum Genet       Date:  2017-05-24       Impact factor: 4.132

Review 9.  Triadopathies: an emerging class of skeletal muscle diseases.

Authors:  James J Dowling; Michael W Lawlor; Robert T Dirksen
Journal:  Neurotherapeutics       Date:  2014-10       Impact factor: 7.620

10.  Congenital myopathies are mainly associated with a mild cardiac phenotype.

Authors:  Helle Petri; Karim Wahbi; Nanna Witting; Lars Køber; Henning Bundgaard; Emna Kamoun; Geoffroy Vellieux; Tanya Stojkovic; Anthony Béhin; Pascal Laforet; John Vissing
Journal:  J Neurol       Date:  2019-03-14       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.